Biotech Jason Mast STAT Plus: Gilead’s twice-yearly antiviral protected women from HIV infection in large trial
Adam's Biotech Scorecard Adam Feuerstein STAT Plus: A primer on HELIOS-B, an enormous stock-moving event for Alnylam Pharmaceuticals
Biotech Matthew Herper STAT Plus: How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease
The Readout Elaine Chen STAT Plus: J.P. Morgan has officially jumped into early stage biotech investing
The Readout LOUD Adam Feuerstein and Allison DeAngelis STAT Plus: Listen: Duchenne gene therapy setback, Alzheimer’s drug endorsement & why a STAT reporter buys weed (for journalism)
Biotech Sarah Owermohle, Allison DeAngelis, and Adam Feuerstein STAT Plus: Biopharma execs cheer Supreme Court for upholding FDA authority in abortion pill case
Biotech Jason Mast STAT Plus: Avidity Biosciences says its experimental drug showed potential against form of muscular dystrophy
Politics Rachel Cohrs Zhang and Elaine Chen STAT Plus: Bernie Sanders calls vote to subpoena Novo Nordisk U.S. head over Ozempic, Wegovy prices
The Readout Elaine Chen Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know
Biotech Allison DeAngelis STAT Plus: Biotech co-founded by entrepreneur Bob Langer is testing a new approach to developing obesity treatments
Biotech Elaine Chen and Adam Feuerstein STAT Plus: FDA advisers unanimously recommend approval of Eli Lilly’s Alzheimer’s disease treatment
Biotech Helen Branswell STAT Plus: Moderna says data show its combination Covid-flu vaccine generates a strong immune response
The Readout LOUD Allison DeAngelis and Adam Feuerstein Listen: Psychedelics at the FDA, ASCO recap, & MorphoSys update
Biotech Jonathan Wosen and Meghana Keshavan STAT Plus: At BIO, signs Congress’ tough stance on China is chilling biotech relationships
Biotech Matthew Herper and Elaine Chen STAT Plus: FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted to a smaller group
Biotech Elaine Chen STAT Plus: Eli Lilly’s obesity drug Zepbound improved liver scarring in mid-stage MASH study
Biotech Adam Feuerstein, Matthew Herper, and Angus Chen STAT Plus: ASCO Takeaways: Winners, snoozers, the China question, and the art of cancer care